Epstein–Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease

This publication has 112 references indexed in Scilit:

• Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
  The Lancet, 2002
• Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded Peptide
  Clinical Immunology, 2001
• Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study
  Transplant International, 2000
• Orchestraton of the immune response: multilevel regulation of diverse regulatory processes
  Current Opinion in Immunology, 1996
• Transmission of donor Epstein--Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients
  Journal of General Virology, 1996
• PATTERNS OF EPSTEIN-BARR VIRUS LATENT AND REPLICATIVE GENE EXPRESSION IN EPSTEIN-BARR VIRUS B CELL LYMPHOPROLIFERATIVE DISORDERS AFTER ORGAN TRANSPLANTATION
  Transplantation, 1994
• Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation.
  The Journal of Experimental Medicine, 1992
• Quantitative Oropharyngeal Epstein-Barr Virus Shedding in Renal and Cardiac Transplant Recipients: Relationship to Immunosuppressive Therapy, Serologic Responses, and the Risk of Posttransplant Lymphoproliferative Disorder
  The Journal of Infectious Diseases, 1992
• Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
  New England Journal of Medicine, 1991
• Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis
  Clinical Immunology and Immunopathology, 1984